Amy L. Burroughs - Net Worth and Insider Trading
Amy L. Burroughs Net Worth
The estimated net worth of Amy L. Burroughs is at least $129,456 dollars as of 2024-05-26. Amy L. Burroughs is the Director of DiaMedica Therapeutics Inc and owns about 44,950 shares of DiaMedica Therapeutics Inc (DMAC) stock worth over $129,456. Details can be seen in Amy L. Burroughs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amy L. Burroughs has not made any transactions after 2021-08-16 and currently still holds the listed stock(s).
Transaction Summary of Amy L. Burroughs
Amy L. Burroughs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Amy L. Burroughs owns 2 companies in total, including DiaMedica Therapeutics Inc (DMAC) , and Tenaya Therapeutics Inc (TNYA) .
Click here to see the complete history of Amy L. Burroughs’s form 4 insider trades.
Insider Ownership Summary of Amy L. Burroughs
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2021-08-16 | director |
| TNYA | Tenaya Therapeutics Inc | 2022-12-05 | director |
Amy L. Burroughs Latest Holdings Summary
Amy L. Burroughs currently owns a total of 1 stock. Amy L. Burroughs owns 44,950 shares of DiaMedica Therapeutics Inc (DMAC) as of August 16, 2021, with a value of $129,456.
Latest Holdings of Amy L. Burroughs
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc | 2021-08-16 | 44,950 | 2.88 | 129,456 |
Holding Weightings of Amy L. Burroughs
Amy L. Burroughs Form 4 Trading Tracker
According to the SEC Form 4 filings, Amy L. Burroughs has made a total of 1 transactions in DiaMedica Therapeutics Inc (DMAC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in DiaMedica Therapeutics Inc is the acquisition of 44,950 shares on August 16, 2021, which cost Amy L. Burroughs around $141,592.
Insider Trading History of Amy L. Burroughs
- 1
Amy L. Burroughs Trading Performance
GuruFocus tracks the stock performance after each of Amy L. Burroughs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Amy L. Burroughs is 23.4%. GuruFocus also compares Amy L. Burroughs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Amy L. Burroughs within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Amy L. Burroughs's insider trading performs compared to the benchmark.
Performance of Amy L. Burroughs
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.1 | | | | | |
| Relative Return to S&P 500(%) | 23.08 | | | | | |
Amy L. Burroughs Ownership Network
Amy L. Burroughs Owned Company Details
What does DiaMedica Therapeutics Inc do?
Who are the key executives at DiaMedica Therapeutics Inc?
Amy L. Burroughs is the director of DiaMedica Therapeutics Inc. Other key executives at DiaMedica Therapeutics Inc include CFO and Secretary Scott Kellen , 10 percent owner Jan Stahlberg , and 10 percent owner Ab Trill .
DiaMedica Therapeutics Inc (DMAC) Insider Trades Summary
Over the past 18 months, Amy L. Burroughs made no insider transaction in DiaMedica Therapeutics Inc (DMAC). Other recent insider transactions involving DiaMedica Therapeutics Inc (DMAC) include a net purchase of 215,000 shares made by Randall Michael Giuffre , a net purchase of 1,470,588 shares made by Koch Thomas Von , and a net purchase of 527,114 shares made by David J. Wambeke .
In summary, during the past 3 months, insiders sold 0 shares of DiaMedica Therapeutics Inc (DMAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,855,847 shares of DiaMedica Therapeutics Inc (DMAC) were sold and 5,177,486 shares were bought by its insiders, resulting in a net purchase of 2,321,639 shares.
DiaMedica Therapeutics Inc (DMAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
DiaMedica Therapeutics Inc Insider Transactions
Amy L. Burroughs Mailing Address
Above is the net worth, insider trading, and ownership report for Amy L. Burroughs. You might contact Amy L. Burroughs via mailing address: Two Carlson Parkway, Suite 260, Minneapolis Mn 55447.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
